Table. Recommendations for MenB vaccine for people with a specified medical condition that increases their risk of invasive meningococcal disease
Age at start of vaccine course | MenB vaccine brand | Dose requirements for people with a specified medical condition associated with increased risk of meningococcal disease |
6 weeks to 5 months | Bexsero | 4 doses (8 weeks between doses; 4th dose at 12 months of age or 8 weeks after 3rd dose, whichever is later) |
6–11 months | Bexsero | 3 doses (8 weeks between 1st and 2nd doses; 3rd dose at 12 months of age or 8 weeks after 2nd dose, whichever is later) |
12 months to 9 years | Bexsero | 2 doses (8 weeks between doses) |
≥10 years | Bexsero | 2 doses (8 weeks between doses) |
Trumenba | 3 doses (at intervals of 0, 1 and 6 months) |
Table. Recommendations for MenACWY vaccine for people with a specified medical condition that increases their risk of invasive meningococcal disease
Table. Recommendations for meningococcal vaccines by age group
This document was printed on: 24/01/2019. Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/resources/handbook-tables/table-recommendations-for-menb-vaccine-for-people-with-a-specified-medical.